BEYONDSPRING PHARMACEUTICALS, INC.
Patent Owner
Stats
- 13 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 31, 2013 most recent publication
Details
- 13 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 611 Total Citation Count
- Nov 12, 1999 Earliest Filing
- 3 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8129527 Analogs of dehydrophenylahistins and their therapeutic useNov 02, 07Mar 06, 12[A61K, C07F, C07D, A61P]
7956058 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereofJun 07, 06Jun 07, 11[A61K, A61P]
7935704 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereofFeb 04, 05May 03, 11[A61K]
7674903 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereofJun 07, 06Mar 09, 10[C07D, A61P]
7064201 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereofAug 01, 03Jun 20, 06[B68B]
7026322 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compoundsAug 01, 03Apr 11, 06[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2006/0223,822 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereofAbandonedJun 07, 06Oct 05, 06[A61K, C07D]
2006/0167,010 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compoundsAbandonedJan 18, 06Jul 27, 06[A61K]
2006/0079,534 Cell division inhibitor and a production method thereofAbandonedNov 17, 05Apr 13, 06[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.